[Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to
450 IU during controlled ovarian hyperstimulation for IVF?]. - Abstract - Europe PMC Sign in …

We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …

We aim to retrospectively evaluate the role of increasing the gonadotropin daily dose from
450 IU/day to 300 IU twice a day on IVF-ET outcome in poor responder patients. All …

Objectives While assisted reproductive technology (ART) activity increases throughout the
world, most teams have to face with the challenge of ovarian stimulation in poor responders …

Objective The efficacy of growth hormone (GH) co-treatment within a GnRH agonist long
regimen, in women with a normal ovarian response to controlled ovarian hyperstimulation …

Objective To compare the outcomes of controlled ovarian stimulation/in vitro fertilization
cycles using 450 IU and 600 IU gonadotropin per day in women at risk of poor ovarian …

Background This large prospective, randomized study was designed to compare the “mild”
protocol with clomiphene citrate, low-dose gonadotropins and a GnRH-antagonist …

Objective: Limited data identify detrimental influences of aggressive use of gonadotropins
(G) for controlled ovarian hyperstimulation (COH); the underlying mechanisms however …

Selecting the most effective protocol for an IVF procedure is still a major challenge for
women known as poor responders to controlled ovarian hyperstimulation (COH). Indeed …

Results Although the duration of r-FSH treatment was a little longer in the mild dosage
group, the total r-FSH dosage and the cost of ovarian stimulation were significantly lower …